La Linea Guida AIOM Tumori dell’Utero ha lo scopo di […]
Search Results for: Dalla presbifagia alla sarcopenia, il trattamento in medicina generale
Here's what we've found for you
Linee guida neoplasia della mammella
Le Linee Guida AIOM Neoplasie della Mammella hanno lo scopo […]
Linee guida tumori del rene
La Linea Guida AIOM Tumori del Rene ha lo scopo […]
Linee guida neoplasia del polmone
Le Linee guida AIOM Neoplasie del polmone hanno lo scopo […]
Linee guida carcinoma del pancreas esocrino
Le Linee guida AIOM sul Carcinoma del pancreas hanno lo […]
Linee guida tumori del colon
Le Linee guida AIOM Tumori del colon hanno lo scopo […]
Linee Guida Neoplasie Cerebrali
Le Linee guida AIOM sulle neoplasie cerebrali hanno lo scopo […]
Analisi comparativa delle linee guida ESC ed ESH sull’ipertensione: Revisione
L’ipertensione rimane una sfida significativa per la salute globale, con […]
Botox, non solo rughe, nuove tossine amplieranno le terapie
Tra novità congresso Aiteb anche trattamento full face e collo
Alzheimer, Irccs S. Raffaele è diventato un centro ricerca e diagnosi precoce
Focus anche sul trattamento innovativo e riabilitativo
Linee Guida per la prevenzione, diagnosi e gestione della BPCO
Questo rapporto del 2025 Global Initiative for Chronic Obstructive Lung […]
Raccomandazioni per la gestione dello stato epilettico refrattario di nuova insorgenza (NORSE), incluso la sindrome epilettica correlata a infezioni febbrili (FIRES): sintesi e strumenti clinici
Il presente studio è stato condotto utilizzando una metodologia Delphi […]
Diabete, le nuove tecnologie rivoluzionano la gestione: sensori, microinfusori e pancreas artificiali
I moderni dispositivi permettono di adattare la terapia insulinica alle esigenze individuali di ciascun paziente, migliorando l’efficacia del trattamento
Linea guida sulla diagnosi e gestione dell’endometriosi
Questa linea guida riguarda la diagnosi e la gestione dell’endometriosi, anche quando […]
Abstract 4145958: Quantification of Sarcopenia in Chest Computed Tomography Prognosticates Cardiac Surgery Outcome
Circulation, Volume 150, Issue Suppl_1, Page A4145958-A4145958, November 12, 2024. Background:Sarcopenia is an objective and comprehensive marker of frailty and an important predictor of outcomes after cardiac surgery. Its utility is challenging due to difficulty in its assessment.Hypothesis:We hypothesize that sarcopenia defined as pectoralis major cross-sectional area (PMA) from CT Chest is a useful predictor of cardiac surgery outcomes.Aim:The aim of this study is to develop Gender Specific Cut-off Points for PMA as a marker for sarcopenia and to evaluate the associations between sarcopenia and post-operative cardiac surgery outcomes.Methods:This study includes 237 subjects with pre-operative CT Chest scans who underwent any Cardiac Surgery involving sternotomy from 2019 to 2023 at the Townsville University Hospital, Australia. The Pectoralis Major Muscle Area, Density and Thickness measurements were performed at the level of 4th thoracic vertebra in Axial view. The sarcopenia cut-off value was defined as the lowest sex-specific quartile in PMA. Intra and post-operative outcomes up to 30-days, were collected.Results:The Cut-off values for PMA were set at 1045mm2for males and 609mm2for females, with 59 subjects meeting the criteria for sarcopenia. Sarcopenic patients required longer hospitalization (10.8±6.93 vs 8.37±5.26 days; P=0.006), longer intubation and stay in ICU, and experienced more post-operative complications within the first 30 days after surgery (p=0.002). Post-operative mortality was similar in both groups.Logistic regression analysis revealed that sarcopenia is associated with increased risk in days of extended hospital stays (OR=5.08, 95% CI: 2.35-10.96, p
Abstract 4122780: Muscle Quality Defines Sarcopenic Obesity in Older Adults In Association with Cardiac Function
Circulation, Volume 150, Issue Suppl_1, Page A4122780-A4122780, November 12, 2024. Background:Obesity phenotypes are increasingly used to define cardiovascular diseases (CVD) risks. Age-related deteriorations in skeletal muscle function have ignited interest in the co-occurrence of sarcopenia and obesity in older adults. However, the traditional definition of sarcopenia (low appendicular skeletal mass [ASM] and handgrip strength [HGS]) may lead to underdiagnosis of sarcopenic obesity (SO) in overweight individuals (due to higher muscle mass). To address this enigma, we evaluated the use of muscle quality (MQ), as an alternative metric for SO, in association with cardiac function.Methods:Community older adults without CVD were prospectively annotated for skeletal mass, HGS and cardiac function via bioimpedance analysis, dynamometer, and simultaneous acquisition of echocardiography respectively. Sarcopenia was defined by low ASM and low HGS. Low MQ (HGS divided by upper body ASM) was defined by males